nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant etanercept improves response in chronic hepatitis C
|
|
|
2005 |
1489 |
1 |
p. 10 |
artikel |
2 |
Alendronic acid fighting FIT to prevent vertebral fracture
|
|
|
2005 |
1489 |
1 |
p. 14 |
artikel |
3 |
Alteplase: resistance to use among ER physicians
|
|
|
2005 |
1489 |
1 |
p. 5 |
artikel |
4 |
ART not associated with major adverse maternal outcomes
|
|
|
2005 |
1489 |
1 |
p. 16 |
artikel |
5 |
Azithromycin microspheres a match for standard therapy
|
|
|
2005 |
1489 |
1 |
p. 15-16 |
artikel |
6 |
Bivalirudin, heparin comparable after PCI with renal impairment
|
|
|
2005 |
1489 |
1 |
p. 10 |
artikel |
7 |
Candesartan cilexetil approved for new indication in US
|
|
|
2005 |
1489 |
1 |
p. 21 |
artikel |
8 |
Capecitabine monotherapy for colorectal cancer in elderly
|
|
|
2005 |
1489 |
1 |
p. 18 |
artikel |
9 |
Ciclosporin effective in myasthenia gravis
|
|
|
2005 |
1489 |
1 |
p. 19 |
artikel |
10 |
Citalopram, sertraline “suitable” antidepressants for elderly
|
|
|
2005 |
1489 |
1 |
p. 13 |
artikel |
11 |
Continuous SSRI therapy associated with lowest costs
|
|
|
2005 |
1489 |
1 |
p. 6 |
artikel |
12 |
Dexloxiglumide accelerates gastric emptying, delays proximal colonic transit
|
|
|
2005 |
1489 |
1 |
p. 6 |
artikel |
13 |
Dextromethorphan abuse may be deadly
|
|
|
2005 |
1489 |
1 |
p. 20 |
artikel |
14 |
Diabetes prevention another reason to value valsartan
|
|
|
2005 |
1489 |
1 |
p. 13 |
artikel |
15 |
Docetaxel + cisplatin in metastatic breast cancer
|
|
|
2005 |
1489 |
1 |
p. 10 |
artikel |
16 |
Doripenem receives a positive opinion in Japan
|
|
|
2005 |
1489 |
1 |
p. 22 |
artikel |
17 |
Doxorubicin + docetaxel-associated adverse events halt study
|
|
|
2005 |
1489 |
1 |
p. 21 |
artikel |
18 |
Early G-CSF reduces febrile neutropenia, death from infection
|
|
|
2005 |
1489 |
1 |
p. 18 |
artikel |
19 |
Early pegfilgrastim reduces febrile neutropenia in elderly
|
|
|
2005 |
1489 |
1 |
p. 19 |
artikel |
20 |
Effective HIV vaccine eludes researchers
|
|
|
2005 |
1489 |
1 |
p. 3 |
artikel |
21 |
Epidural morphine reduces oral pain medication use postpartum
|
|
|
2005 |
1489 |
1 |
p. 12 |
artikel |
22 |
Escitalopram launched in France
|
|
|
2005 |
1489 |
1 |
p. 22 |
artikel |
23 |
Esomeprazole may reduce NSAID-induced upper GI disorders
|
|
|
2005 |
1489 |
1 |
p. 20 |
artikel |
24 |
EU product approvals
|
|
|
2005 |
1489 |
1 |
p. 21 |
artikel |
25 |
Everolimus approved by Swissmedic for heart and renal transplantation
|
|
|
2005 |
1489 |
1 |
p. 22 |
artikel |
26 |
High-dose mesalazine effective, safe in UC
|
|
|
2005 |
1489 |
1 |
p. 13 |
artikel |
27 |
High-dose pregabalin all round tonic in fibromyalgia
|
|
|
2005 |
1489 |
1 |
p. 5 |
artikel |
28 |
High vs moderate potency topical corticosteroids in phimosis
|
|
|
2005 |
1489 |
1 |
p. 18 |
artikel |
29 |
HIV/AIDS drug price not the “rate-limiting factor” it was once thought
|
|
|
2005 |
1489 |
1 |
p. 3 |
artikel |
30 |
Improved paediatric antineoplastics required
|
|
|
2005 |
1489 |
1 |
p. 3 |
artikel |
31 |
Infliximab induces short-term response in paediatric UC
|
|
|
2005 |
1489 |
1 |
p. 18 |
artikel |
32 |
In utero SRI exposure and neonatal behavioural syndrome
|
|
|
2005 |
1489 |
1 |
p. 20 |
artikel |
33 |
Is iNO worth the effort in hypoxic respiratory failure?
|
|
|
2005 |
1489 |
1 |
p. 14 |
artikel |
34 |
Kaken Pharmaceuticals' hyaluronan approved for additional indication
|
|
|
2005 |
1489 |
1 |
p. 22 |
artikel |
35 |
Long-acting risperidone most economical choice in schizophrenia
|
|
|
2005 |
1489 |
1 |
p. 4 |
artikel |
36 |
Losartan, not spironolactone, reduces LVM and sympathetic activity
|
|
|
2005 |
1489 |
1 |
p. 19 |
artikel |
37 |
Miconazole in oropharyngeal candidiasis
|
|
|
2005 |
1489 |
1 |
p. 9 |
artikel |
38 |
Migraine drug prophylaxis eases cost headache for US health plans
|
|
|
2005 |
1489 |
1 |
p. 6 |
artikel |
39 |
Muraglitazar may reduce HbA1c levels in diabetes
|
|
|
2005 |
1489 |
1 |
p. 8 |
artikel |
40 |
Naproxen/sumatriptan a single-tablet attack on migraine
|
|
|
2005 |
1489 |
1 |
p. 7-8 |
artikel |
41 |
Nebivolol reduces BP in hypertension
|
|
|
2005 |
1489 |
1 |
p. 18 |
artikel |
42 |
NGX 4010 may reduce HIV-associated sensory neuropathy
|
|
|
2005 |
1489 |
1 |
p. 9 |
artikel |
43 |
Oblimersen feasible in relapsed multiple myeloma
|
|
|
2005 |
1489 |
1 |
p. 9 |
artikel |
44 |
Olanzapine worth its cost in treatment of acute mania
|
|
|
2005 |
1489 |
1 |
p. 4 |
artikel |
45 |
Once-daily abacavir could be on the charts for HIV-1 infections
|
|
|
2005 |
1489 |
1 |
p. 14 |
artikel |
46 |
Orlistat receives positive opinion in the EU
|
|
|
2005 |
1489 |
1 |
p. 22 |
artikel |
47 |
Other US regulatory news
|
|
|
2005 |
1489 |
1 |
p. 22 |
artikel |
48 |
Oxymorphone ER effective for moderate-to-severe osteoarthritis pain
|
|
|
2005 |
1489 |
1 |
p. 12 |
artikel |
49 |
Palonosetron pharmacokinetics unaffected by aprepitant coadministration
|
|
|
2005 |
1489 |
1 |
p. 19 |
artikel |
50 |
Paromomycin receives orphan drug designation in US, EU
|
|
|
2005 |
1489 |
1 |
p. 22 |
artikel |
51 |
Pegaptanib approved in Brazil for wet age-related macular degeneration
|
|
|
2005 |
1489 |
1 |
p. 22 |
artikel |
52 |
Quadrivalent HPV vaccine immunogenic, safe
|
|
|
2005 |
1489 |
1 |
p. 8 |
artikel |
53 |
Ringing the changes in contraceptive methods
|
|
|
2005 |
1489 |
1 |
p. 14 |
artikel |
54 |
Sale, distribution of saquinavir to be discontinued in US
|
|
|
2005 |
1489 |
1 |
p. 22 |
artikel |
55 |
Sertraline treatment of depression in ACS worthwhile
|
|
|
2005 |
1489 |
1 |
p. 5 |
artikel |
56 |
Sevoflurane, not propofol, conserves cardiac function during bypass
|
|
|
2005 |
1489 |
1 |
p. 19 |
artikel |
57 |
Simvastatin promotes plaque regression after stenting
|
|
|
2005 |
1489 |
1 |
p. 13 |
artikel |
58 |
Sinapultide may confer benefit in premature neonates
|
|
|
2005 |
1489 |
1 |
p. 9 |
artikel |
59 |
STA 5326 may induce response, remission in Crohn's disease
|
|
|
2005 |
1489 |
1 |
p. 6 |
artikel |
60 |
Tacrolimus a long-term option in cadaveric renal transplantation
|
|
|
2005 |
1489 |
1 |
p. 18 |
artikel |
61 |
Tegaserod improves symptoms in upper GI disorders
|
|
|
2005 |
1489 |
1 |
p. 10 |
artikel |
62 |
TH 070 may improve symptoms of BPH
|
|
|
2005 |
1489 |
1 |
p. 9 |
artikel |
63 |
Topotecan an oral alternative in lung cancer
|
|
|
2005 |
1489 |
1 |
p. 11-12 |
artikel |
64 |
Treatment of dyslipidaemia in primary care inadequate
|
|
|
2005 |
1489 |
1 |
p. 2 |
artikel |
65 |
US generic approvals and launches
|
|
|
2005 |
1489 |
1 |
p. 21 |
artikel |
66 |
US product launches
|
|
|
2005 |
1489 |
1 |
p. 21 |
artikel |
67 |
Voriconazole a wise choice in invasive aspergillosis
|
|
|
2005 |
1489 |
1 |
p. 4 |
artikel |
68 |
VX 950 may reduce HCV RNA levels in HCV
|
|
|
2005 |
1489 |
1 |
p. 9 |
artikel |
69 |
When and with what? The ART to treating paediatric HIV
|
|
|
2005 |
1489 |
1 |
p. 3 |
artikel |